InvestorsHub Logo
Followers 37
Posts 2036
Boards Moderated 0
Alias Born 09/29/2007

Re: None

Thursday, 10/15/2009 12:10:36 AM

Thursday, October 15, 2009 12:10:36 AM

Post# of 1605
Old, but info on MVax study results on May 2000.

AVAX Technologies' M-Vax™ cancer vaccine extends five-year overall survival in patients with lymph node metastatic melanoma

http://news.bio-medicine.org/biology-news-2/AVAX-Technologies-M-Vax-26-23153-cancer-vaccine-extends-five-year-overall-survival-in-patients-with-lymph-node-metastatic-melanoma-11470-1/